Table of Contents Table of Contents
Previous Page  8 / 8
Information
Show Menu
Previous Page 8 / 8
Page Background

Volume 8

Journal of Gastrointestinal & Digestive System

ISSN: 2161-069X

Gastro Congress 2018

August 20-21, 2018

Page 59

Notes:

conference

series

.com

August 20-21, 2018 | Rome, Italy

13

th

Euro-Global

Gastroenterology Conference

Davor Štimac, J Gastrointest Dig Syst 2018, Volume 8

DOI: 10.4172/2161-069X-C5-075

Endoscopic treatment of obesity: Challenge for gastroenterologists

A

ccording to emerging role of endoscopic procedures in the treatment of obesity and rapid changes in endoscopic technologies

and techniques, the current state of endoscopic management of obesity will be presented. Endoluminal interventions

performed entirely through the GI tract by using flexible endoscopy offer the potential for an ambulatory weight loss procedure

that may be safer and more cost-effective compared with current surgical approaches. Endoscopic techniques attempt to mimic

the anatomic features of bariatric surgery. Accordingly, there are two main endoscopic weight loss modalities - restrictive and

malabsorptive. Restrictive procedures act to decrease gastric volume by space-occupying prosthesis and/or by suturing or stapling

devices, while malabsorptive procedures tend to create malabsorption by preventing food contact with the duodenum and

proximal jejunum. The former include intragastric balloon treatment, endoluminal vertical gastroplasty, transoral gastroplasty

and transoral endoscopic restrictive implant system, while the latter include duodenojejunal bypass sleeve. Gastroduodenojejunal

bypass sleeve is a combination of both procedures. Except for intragastric balloon, all mentioned procedures are rather new, tested

on a small number of human subjects, with a high rate of success, but with limited knowledge on safety and long-term efficacy.

The role of gastric electrical stimulation and intragastric injections of botulinum toxin in obesity treatment is also considered as is

the role of minimally invasive bariatric endoscopic interventions.

Biography

Davor Štimac is a Professor in the university of rijeka. He is Director of Clinical Hospital Center Rijeka from 2016. Head of the Clinic for Internal Medicine of the

Clinical Hospital Center Rijeka from the year 2014. Deputy Head of the Department of Internal Medicine of the Faculty of Medicine of the University of Rijeka from the year

2001. He is member in the following societies, Croatian Medical Association- member of the Executive Board, Croatian Gastroenterological Society - Member

of the Steering Committee, Croatian Pancreatic Club –President, Croatian Society for Thickness - the President, Croatian Society for Health Care Quality

Improvement-Vice President, World Gastroenterology Organization (WGO)- a member of the Global Guidelines and Publication Board and a member of the

Trainers' Trainers (TTT), United European Gastroenterology Federation (UEGF)- a member of the General Assembly, European Association of Gastroenterology,

Endoscopy and Nutrition (EAGEN)- Member of the Board of Directors, European Board for Gastroenterology and Hepatology (EBGH)- Member of the

Management Board, UEMS Section for Gastroenterology- HLZ representative. He had published about 121articles. Editor for 7 books and had 21 chapters in

the books, 71 work in other indices.

davor.stimac@ri.ht.hr

Davor Štimac

Clinical Hospital Center of Rijeka - University of Rijeka, Croatia